# Johnson & Johnson (JNJ) — Q2-2009 Earnings Results

**Report date:** 2009-07-14 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2009

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.15 | N/A | +2.95% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook despite not providing specific guidance. They emphasized the importance of innovation and market adaptability.

**Key quotes:**

> Management expressed confidence in the company's long-term growth potential.

> They highlighted ongoing investments in research and development.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report indicates that Johnson & Johnson is performing slightly better than expected in terms of earnings per share. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction is not available, but the positive EPS surprise suggests some level of investor confidence.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2009_